Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses - PubMed
- ️Wed Jan 01 1992
Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses
A Baniahmad et al. Proc Natl Acad Sci U S A. 1992.
Abstract
Mutations in the gene encoding the human thyroid hormone receptor beta (hTR beta) have been associated with generalized thyroid hormone resistance (GTHR). However, the molecular basis by which the receptor mutants cause the clinical symptoms is largely unknown. We show here that the beta form of the human receptor possesses, in addition to hormone-dependent activation, the ability to repress basal-level activity of a target promoter. This silencing function is localized in the carboxyl-terminal part of the receptor and can be transferred to a heterologous DNA binding domain. This mode of silencing is therefore distinct from inhibition by competition with activator proteins on DNA. We show that two receptor mutants isolated from patients with GTHR are impaired in transcriptional activation but fully retain the silencing function, which enforces dominant negative regulation by the receptor. Interestingly, the kindred S receptor (hTR delta 332) acts as a constitutive repressor with a strong silencing ability similar to that of the v-erbA oncogene product. We also provide evidence for distinct transcriptional regulatory properties of both proteins. Finally, we show that both thyroid hormone- and retinoic acid-responsive genes are potentially repressed to generate the clinical manifestations of the GTHR syndrome. Our findings suggest that silencing plays an important role in the phenotypic expression of the symptoms in patients with GTHR.
Similar articles
-
Saatcioglu F, Bartunek P, Deng T, Zenke M, Karin M. Saatcioglu F, et al. Mol Cell Biol. 1993 Jun;13(6):3675-85. doi: 10.1128/mcb.13.6.3675-3685.1993. Mol Cell Biol. 1993. PMID: 8098843 Free PMC article.
-
Sakurai A, Miyamoto T, Refetoff S, DeGroot LJ. Sakurai A, et al. Mol Endocrinol. 1990 Dec;4(12):1988-94. doi: 10.1210/mend-4-12-1988. Mol Endocrinol. 1990. PMID: 2082193
-
Privalsky ML, Sharif M, Yamamoto KR. Privalsky ML, et al. Cell. 1990 Dec 21;63(6):1277-86. doi: 10.1016/0092-8674(90)90423-c. Cell. 1990. PMID: 1979758
-
Lutz M, Baniahmad A, Renkawitz R. Lutz M, et al. Biochem Soc Trans. 2000;28(4):386-9. Biochem Soc Trans. 2000. PMID: 10961925 Review.
-
ErbA: tumor suppressor turned oncogene?
Damm K. Damm K. FASEB J. 1993 Jul;7(10):904-9. doi: 10.1096/fasebj.7.10.8102105. FASEB J. 1993. PMID: 8102105 Review.
Cited by
-
Hadzic E, Desai-Yajnik V, Helmer E, Guo S, Wu S, Koudinova N, Casanova J, Raaka BM, Samuels HH. Hadzic E, et al. Mol Cell Biol. 1995 Aug;15(8):4507-17. doi: 10.1128/MCB.15.8.4507. Mol Cell Biol. 1995. PMID: 7623841 Free PMC article.
-
Casanova J, Helmer E, Selmi-Ruby S, Qi JS, Au-Fliegner M, Desai-Yajnik V, Koudinova N, Yarm F, Raaka BM, Samuels HH. Casanova J, et al. Mol Cell Biol. 1994 Sep;14(9):5756-65. doi: 10.1128/mcb.14.9.5756-5765.1994. Mol Cell Biol. 1994. PMID: 8065310 Free PMC article.
-
Tong GX, Jeyakumar M, Tanen MR, Bagchi MK. Tong GX, et al. Mol Cell Biol. 1996 May;16(5):1909-20. doi: 10.1128/MCB.16.5.1909. Mol Cell Biol. 1996. PMID: 8628257 Free PMC article.
-
Abel ED, Kaulbach HC, Campos-Barros A, Ahima RS, Boers ME, Hashimoto K, Forrest D, Wondisford FE. Abel ED, et al. J Clin Invest. 1999 Jan;103(2):271-9. doi: 10.1172/JCI5205. J Clin Invest. 1999. PMID: 9916139 Free PMC article.
-
Baniahmad A, Ha I, Reinberg D, Tsai S, Tsai MJ, O'Malley BW. Baniahmad A, et al. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8832-6. doi: 10.1073/pnas.90.19.8832. Proc Natl Acad Sci U S A. 1993. PMID: 8415616 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources